Table 1

Baseline demographic and anthropometric characteristics of the study population (n=116)

Mean (SD)Median (Q1, Q3)n (%)
Age (years)70.4 (7.2)71 (65, 76)
 <609 (8)
 60–6940 (35)
 70–7956 (48)
 ≥8011 (10)
Ethnicity (white)114 (98)
Marital status (married/partner)102 (88)
Retirement (retired)89 (77)
Smoking status (current smoker)2 (2)
IMD7.5 (5, 9)
 1–3 (most deprived)16 (14)
 4–624 (21)
 7–837 (32)
 9–10 (least deprived)39 (34)
CCI2 (2, 3)
 ≤2 (mild)84 (72)
 3–4 (moderate)16 (28)
 ≥5 (severe)0 (0)
CCI age adjusted score6 (5, 6)
PAM score3 (2, 3)
 Level 1 (lowest)15 (13)
 Level 216 (14)
 Level 358 (50)
 Level 4 (highest)25 (22)
 Missing2 (2)
Time since diagnosis (years)1.5 (0.7)
 ≤172 (62)
 >136 (31)
 Missing8 (7)
Treatment
 Surgery49 (42)
 Radiotherapy69 (60)
 Brachytherapy4 (4)
 ADT66 (57)
Number of participants per pharmacy
 A21 (18)
 B19 (8)
 B28 (7)
 B39 (8)
 B418 (16)
 C130 (26)
 C28 (7)
 C34 (3)
 C49 (8)
Anthropometrics
Weight (kg)86.9 (14.0)
BMI (kg/m2)28.1 (4.1)
BMI  ≥25 kg/m2 (overweight/obese)91 (78)
Waist circumference (cm)102.8 (11.0)
Obese, waist circumference ≥102 cm63 (54)
Waist-to-hip ratio0.97 (0.06)
Waist-to-hip ratio >0.90 (obese)101 (87)
Total cholesterol (mmol/L)4.7 (1.3)
Cholesterol ratio4.0 (1.3)
Systolic blood pressure (mm Hg)134 (16)
Diastolic blood pressure (mm Hg)81 (11)
Cardiovascular health
QRisk225.6 (11.3)
QRisk2 ≥20 (high risk)83 (72)
Accelerometry data
Counts per day (1000 counts)271 (100)
MVPA per week (min)245 (250)
MVPA per week in ≥10 min bouts (min)31 (67)
Achieving CMO guidance (N, %)8 (7%)
Fitness and strength
Upper-limb strength (grip strength) (kg)35.7 (6.7)
 Low69 (59)
 Moderate22 (19)
 High25 (22)
Lower-limb strength (sit-to-stands in 30 seconds)13 (10, 15)
 Low55 (47)
 Moderate48 (41)
 High13 (11)
Physical fitness (Siconolfi step test)
 Low49–42
 Moderate38–33
 High29–25
  • ADT, androgen deprivation therapy; BMI, body mass index; CCI, Charlson comorbidity index; CMO, chief medical office; IMD, index of multiple deprivation; MVPA, moderate to vigorous physical activity; PAM, patient activation measure; Q1, 25th percentile; Q3, 75th percentile; QRisk2, QRisk2 2017 cardiovascular disease risk calculator (qrisk.org/2017).